GLYDE MOBILITY CHEWS FOR DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

GREEN LIPPED MUSSEL; SODIUM CHONDROITIN SULFATE; GLUCOSAMINE HYDROCHLORIDE

Available from:

PARNELL TECHNOLOGIES PTY LTD

INN (International Name):

sodium chondroitin sulfate(285mg/chew)+glucosamine HCl(570mg/chew) + others

Pharmaceutical form:

ORAL TABLET

Composition:

GREEN LIPPED MUSSEL EXTRACT-ANIMAL Active 760.0 mg; SODIUM CHONDROITIN SULFATE CARBOHYDRATE Active 285.0 mg; GLUCOSAMINE HYDROCHLORIDE CARBOHYDRATE-GLUCOSE Active 570.0 mg

Units in package:

120 chews; 30 chews; 60 chews; 7 chews

Class:

VM - Veterinary Medicine

Manufactured by:

PARNELL TECHNOLOGIES

Therapeutic area:

MUSCULOSKELETAL SYSTEM

Product summary:

Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [IMPROVE JOINT FUNCTION]; Long term treatment with GLYDE aids in improvement of joint health and function in dogs. Suitable for use in active or ageing dogs.Use in pregnant animals is not recommended as safe use in pregnant animals has not been tested.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

'
APPENDIX2
RLP
Approved
TEMPLATE FOR RELEVANT
LABEL
PARTICULARS (RLPs)
(Veterinary
Products)
Select appropriate:
--/New Product (include all applicable
RLPs)
OR
[J
Variation (highlight instructions that are being varied). Approval
no.
of
label being varied:
Signal
heading:
FOR
ANIMAL TREATMENT ONLY
Product name:
GL
YDE
MOBILITY CHEWS
FOR
DOGS
Active constituent/s:
Each c.tlew
contains Chondroitin Sulfate Sodium (Bovine Origin) 285mg,
Glucosamine Hydrochloride 570mg, Green Lipped Mussel Powder 760mg
(3g per chew)
Statement
of
claims:
Long-term treatment with GL YDE aids in improvement
of
joint
health
and
function in dogs. Suitable
for
use
in
active
or
ageing dogs.
This product
is
registered as a complementary Animal Health Product.
Net contents:
7,
30,
60
and 120 Chews (3g per Chew)
Directions for
Use
Heading:
Restraints:
Use
in
pregnant animals
is
not
recommended
as
safe use
in
pregnant
animals has
not
been established.
Contraindications:
Not Applicable
Precautions:
GL
YDE
CAN NOT BE RECOMMENDED
AS
AN
ALTERNATIVE TREATMENT
IN
ACUTE JOINT INFLAMMATION.
LONG
TERM
TREATMENT
IS
REQUIRED
Side effects:
Not Applicable
Dosage
&
Initial Period:
4-
6 weeks: 1 chew per 10kg bodyweight per day
for
4-6
administration:
weeks
Maintenance dose:
112
chew per 1
Okg
bodyweight per day
1 chew
=
3g approx.
DOSAGE
GUIDE
Number
of
Chews
Daily
Bodyweight
(kg)
Initial
Treatment
Maintenance
Treatment
4-6
weeks
s-
to
1 chew
V2
chew
11
- 20
2 chews
1 chew
21
- 30
3 chews
1 %chews
31
- 40
4 chews
2
chews
Over
40
5
chews
2 %chews
General directions:
GL
YDE
Mobility Chews
for
Dogs is a medication that may help relieve
the
symptoms
of
arthritis in dogs.
Cartilage acts as a cushion between the bones of joints.
Glycosaminoglycans (GAGs) form the major building
blocks
of
cartilage and
the lubricating
fluid
within the joint. In arthritis, cartilage becomes damaged
leading to clinical signs such
as
stiffness, pain, a reluctance to run or
play
and lameness
in
the affected limbs.
GLYDE contains three separate biological compounds:
./
Glucosamine-
a p